Overview
Commonwealth Fusion Systems (CFS) is developing compact tokamak fusion reactors using high-temperature superconducting (HTS) magnets. The company was spun out of MIT's Plasma Science and Fusion Center in 2018 by a team led by CEO Bob Mumgaard, with MIT physics professor Dennis Whyte as a key scientific co-founder. Its central technical thesis, that a new class of superconducting materials enables magnets strong enough to make fusion reactors dramatically smaller and faster to build than previously possible, was experimentally validated in September 2021 when CFS achieved a 20 tesla magnetic field in a large-bore superconducting magnet, a world record that confirmed the scientific foundation of its approach.
CFS raised approximately $1.8 billion in a December 2021 Series B, one of the largest private clean energy raises at the time, led by Tiger Global and joined by Google, Khosla Ventures, and Breakthrough Energy Ventures. It added an $863 million round in August 2025 whose new investors included NVIDIA's venture arm, with Google, Eni, and Breakthrough Energy increasing their stakes. A further $1 billion announced on July 30, 2026 brought total capital raised to about $4 billion, which CFS says is roughly 30% of all capital raised across the fusion industry. CFS is building its demonstration reactor, SPARC, in Devens, Massachusetts, and targets first plasma and net energy gain in 2027. Its first commercial power plant, ARC, will be built in Chesterfield County, Virginia.
The technology
Fusion energy (the same reaction that powers the sun) releases energy by fusing light atomic nuclei (typically deuterium and tritium, both isotopes of hydrogen) under extreme heat and pressure. The engineering challenge is confining a plasma at 100 million degrees Celsius, far hotter than the sun's core, long enough and densely enough to sustain a net-positive energy reaction. Tokamaks, donut-shaped magnetic confinement devices, are the most mature approach to achieving this. ITER, the international fusion project under construction in France, is a tokamak, and it is enormous: roughly 30 meters tall, 28,000 tonnes, costing approximately €20 billion.
CFS's insight is that fusion performance scales steeply with magnetic field strength, roughly as the fourth power of the magnetic field. Conventional fusion programs like ITER use low-temperature superconducting (LTS) magnets that max out at around 10–13 tesla. A new class of materials, rare-earth barium copper oxide (REBCO) tape, a high-temperature superconductor, can sustain superconductivity in much higher fields and at the more manageable temperature of liquid nitrogen (77 K rather than 4 K). CFS has developed the manufacturing and engineering techniques to wind REBCO tape into high-field magnets at scale. The result: a 20 tesla magnet demonstrated in September 2021, roughly double the field of conventional fusion magnets.
Because fusion performance scales so steeply with field strength, doubling the magnetic field allows plasma volume to shrink by approximately 16-fold for equivalent fusion performance. SPARC, the demonstration reactor, will have a plasma volume roughly 1/65th that of ITER while targeting net energy gain, a fusion energy gain (Q) greater than 1, with a design point around Q of 11. If achieved, this would be the first demonstration of net energy gain from a magnetic-confinement tokamak. The compact form factor also means SPARC can be built in years rather than decades and at a cost in the hundreds of millions rather than tens of billions.
SPARC and ARC
Funding & investors
CFS has raised about $4 billion since 2018, more than any other fusion company. The December 2021 Series B of approximately $1.8 billion was led by Tiger Global, with Google, Khosla Ventures, and Breakthrough Energy Ventures participating. An $863 million round in August 2025 added NVIDIA's venture arm and saw Google, Eni, and Breakthrough Energy increase their stakes.
The $1 billion announced on July 30, 2026 is the largest fusion round since the 2021 Series B. CFS did not name the participants or disclose a valuation, describing the new money as institutional capital including pension funds, sovereign wealth funds, infrastructure investors, and industrial corporate partners. Pension and sovereign wealth funds price to infrastructure returns rather than venture outcomes, and CFS presents their arrival as evidence that fusion is starting to be underwritten as an infrastructure asset.
Lorence Kim, Moderna's CFO through its 2018 IPO, joined CFS as chief financial officer in July 2026. Kim has said his hiring should not be read as IPO preparation, though coverage of the round put a listing two to three years out. Mumgaard has said the Virginia plant will need additional billions of dollars, though not tens of billions, beyond what CFS has raised.
Strategy & outlook
CFS operates on a faster timeline than any previous fusion program. The company targets first plasma on SPARC in 2027, a date that is ambitious by the standards of fusion engineering but plausible given that the primary technical risk, high-field magnet performance, has been experimentally resolved. The remaining work is engineering execution: manufacturing magnets at production volume, assembling the tokamak, and managing the plasma physics of a burning plasma for the first time outside a national laboratory.
The commercial proposition, if SPARC succeeds, is a fusion power plant that is small enough to be built at a manufacturing facility and shipped to site, firm enough to provide baseload power, and fueled by effectively inexhaustible materials. CFS is not alone in pursuing compact fusion; TAE Technologies, Helion Energy, and others have raised significant capital. Among them, CFS is notable for publishing its physics basis in peer-reviewed journals and for setting one of the nearest-term net-energy milestones.
Key considerations
Fusion has been "20 years away" for 70 years. CFS has resolved the magnet problem, which was the key technical gating item for compact fusion. But a burning plasma, one that is self-sustaining from fusion reactions, has never been achieved in any private or public fusion device. SPARC will be the first attempt at net gain in a tokamak outside of the National Ignition Facility's laser-based approach. The gap between achieving net gain in a demonstration device and producing reliable, cost-competitive commercial power involves decades of engineering, materials science, and regulatory work that even optimistic timelines leave to the 2030s and beyond. First plasma was originally targeted for 2025, then 2026, and CFS now points to 2027 for both first plasma and net energy gain. Assembly has continued through the reschedule, but the remaining work is first-of-a-kind engineering with no precedent to schedule against.
The tritium fuel cycle presents a significant engineering challenge. Tritium is produced in limited quantities as a byproduct of fission reactors and is radioactive with a 12-year half-life. Commercial fusion plants must breed their own tritium from lithium blankets inside the reactor, a technology that has never been demonstrated at scale. Getting the tritium breeding ratio above 1.0 (self-sustaining) is one of the key engineering milestones between SPARC and ARC. CFS and the broader fusion community are aware of this; it is simply one of many unsolved engineering challenges that stand between today's demonstrations and commercial power.
Sources
This profile was compiled from publicly available information including:
CFS Newsroom — Technical milestones, funding announcements, and reactor design updates.
Greenwald, M., et al. "SPARC physics basis." Journal of Plasma Physics, Special Issue, September 2020. Peer-reviewed design basis for the SPARC tokamak.
CFS 20 tesla magnet demonstration (September 2021); Series B (December 2021), $863 million Series B2 (August 2025), and $1 billion (July 30, 2026) funding announcements; ARC Virginia siting announcement (December 2024); Google and Eni offtake agreements (2025); PJM interconnection application (April 2026). Eni offtake value as reported by TechCrunch.
This profile is for informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. CFS is a private company; financial data is limited to publicly disclosed information.